BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0770
-0.0060 (-7.23%)
May 18, 2026, 3:01 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 28.39 million as of May 18, 2026. Its market cap has decreased by -26.12% in one year.
Market Cap
28.39M
Enterprise Value
28.50M
Revenue
2.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 28.39M, a decrease of -45.11%. That is a compound annual growth rate of -11.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 30.60M | -20.82% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | 51.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 353.56M |
| Monash IVF Group | 284.43M |
| Healius | 250.52M |
| Rhythm Biosciences | 50.43M |
| Cryosite | 48.81M |
| Microba Life Sciences | 46.89M |
| INOVIQ | 45.05M |
| ImExHS | 20.01M |